Webinar

Generation of Recombinant
Tool Antibodies to Support Cell
and Gene Therapy
Development


Sophie Mayle

with Sophie Mayle
Technical Sales Specialist,
Bio-Rad Laboratories

Watch on‑demand in French
Watch on‑demand in German
Watch on‑demand in Italian

Highly specialized antibodies are required for cellular kinetics and bioanalytical assays supporting cell and gene therapy. But these antibodies are difficult to generate using traditional animal immunization, and are prone to batch variability and inconsistent supply.

Bio-Rad antibody experts have developed recombinant antibodies against chimeric antigen receptors and transgene products using our TrailBlazer Antibody custom service. The process combines antibody phage display with our new modular platform based on SpyTag technology.

Join this webinar to hear how the combination of these powerful technologies enables the rapid construction of antibodies in multiple formats in as little as 9 weeks, and offers a range of options for site-directed conjugation. These highly specific antibodies are sequence defined, guaranteeing a secure supply throughout the assay lifecycle.

Sophie Mayle

Sophie Mayle
Technical Sales Specialist,
Bio-Rad Laboratories

Sophie Mayle is a Technical Sales Specialist for Bio-Rad’s Custom Antibody Service for the UK and Nordic countries, and has been with
Bio-Rad for over 4 years. Prior to this, she worked for an antibody therapeutics company, IONTAS. Sophie holds a degree from the University of Sheffield (UK), and a PhD and post-doctoral research experience from the University of Cambridge (UK).